Pfizer and Astellas' XTANDI® Combo Proves Effective in Reducing Prostate Cancer Metastasis Risk by 58%: Phase 3 EMBARK Trial Results Revealed

Data from Phase 3 EMBARK trial to be presented as a plenary session during the 2023 American Urological Association Annual Meeting Res...

May 01, 2023 | Monday | News
Janssen Reports First Results of TAR-200 and Cetrelimab Study in Non-Muscle-Invasive Bladder Cancer

Study results of novel drug-eluting technology highlight potential durability of TAR-200 in patient population with high unmet need T...

May 01, 2023 | Monday | News
Brenus Pharma Unveils Preclinical Results for Promising New Cancer Drug STC-10101

Brenus Pharma Announces two groundbreaking presentations on STC-1010, the company's first drug candidate for colorectal cancer (CRC), produced by Brenus Ph...

April 28, 2023 | Friday | News
Corning's New Advanced Flow Pharmaceutical Technology Services Will Help Speed the Creation of Future Medicines

Corning Incorporated  announced the launch of its Advanced Flow Pharmaceutical Technology (AFPT) services business to help contract development m...

April 27, 2023 | Thursday | News
Amicus Therapeutics Receives Positive CHMP Opinion for Opfolda® (miglustat) for Late-Onset Pompe Disease

European Commission Approval of Opfolda and Commercial Launch of Pombiliti® + Opfolda® Anticipated in 3Q 2023   Upon Approval, Pombiliti + O...

April 27, 2023 | Thursday | News
Roche's Columvi Gets CHMP Nod for Fixed-Duration Use in Diffuse Large B-cell Lymphoma

The recommendation is based on results from the phase I/II NP30179 study, where Columvi given as a fixed course induced early and long-lasting complete r...

April 27, 2023 | Thursday | Regulatory
Cytiva backs BioCina's first GMP facility for mRNA in Australia

Expanded facility to manufacture mRNA-based therapies and vaccines  Researchers at the University of Adelaide will address the design and manufacturi...

April 26, 2023 | Wednesday | News
Mass Spectrometry Explained: How LC/MS/MS Works

Triple quadrupole mass spectrometers (LC/MS/MS) are established in labs dealing with challenging matrices, as they offer very low detection limits with spe...

April 25, 2023 | Tuesday | News
Simcere Pharma on Fast Track to Becoming Innovation-Driven Global Company with Four New Drug Launches in Three Years

-The revenue from innovative drugs accounted for more than 65% of total revenue  -Simcere's total revenue and the revenue from in...

April 24, 2023 | Monday | News
Sanofi Launches AVAXIM® Junior in UK for Hepatitis A Virus Immunisation in Children

Sanofi (EURONEXT: SAN and NASDAQ: SNY) has today announced the launch of AVAXIM® Junior in the UK, an inactive hepatitis A vaccine indicated for use in...

April 24, 2023 | Monday | News
CPC Launches Biopharma's Largest Aseptic Connector

"Biopharma manufacturers continue to press the boundaries of single-use technologies (SUTs) in nearly all of their production processes, including the use ...

April 22, 2023 | Saturday | News
Daewoong Pharmaceutical and Sygnature Discovery announce drug discovery research collaboration

Daewoong Pharmaceutical has entered a research collaboration with Sygnature Discovery to expand its global open innovation for novel drug development. On ...

April 19, 2023 | Wednesday | News
HUTCHMED Announces NDA Acceptance in China for Fruquintinib in Second-Line Gastric Cancer

Dr. Michael Shi, Head of R&D and Chief Medical Officer of HUTCHMED said, “The NMPA acceptance of our NDA for fruquintinib is a positive step towa...

April 18, 2023 | Tuesday | Regulatory
Adaptive Biotech, Takeda collaborate to measure disease with clonoSEQ® assay.

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune sy...

April 14, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close